Cesarean Wound DisruptionNCT04587960
Delayed Primary Closure of Skin in Emergency Caesarean Section
A study testing Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group in people with Cesarean Wound Disruption and Cesarean Section; Infection, run by Dr.Jhuma Biswas at 1 site in India.
Trial summary
Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to… Read more about this study
- Who is it for?
- Ages 21 to 40 years, women only
- Conditions the study is for
- Cesarean Wound Disruption, Cesarean Section; Infection
- What is being tested?
- Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteIndia
- Study dates
- 1 Mar 2021to 15 Jun 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Parturients admitted with rupture of membranes undergoing emergency CS
Who cannot join
- Presence of intact membranes
- Incision other than Pfannenstiel
- Presence of pre-existing infection at the site of skin incision
- Presence of obvious chorioamnionitis
- Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
- Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.
Trial locations and contacts
1 site in 1 country.
India1 site
Calcutta National Medical College and Hospital
Kolkata, West Bengal, 700047
About this study
Official title: Comparative Study of Outcome Between Primary Closure and Delayed Primary Closure of Skin Incision in Emergency Caesarean Section
Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.
Read the detailed description
OBJECTIVE
- To compare the effect of two different methods of skin wound closure namely Primary Closure and Delayed Primary Closure on the incidence of wound infection and requirement for secondary skin wound repair after emergency caesarean section in patients with ruptured membranes.
RESEARCH HYPOTHESIS Caesarean Sections (CS) in emergency situation where amniotic membrane is ruptured are clean contaminated procedures which are associated with 10-20% wound disruptions. Delayed Primary Closure for managing contaminated wounds is a concept well recognized by military surgeons, which reduces wound infections. Investigators wish to conduct this prospective study to determine the efficacy of using this technique of wound closure in Caesarean Sections in patients with history of ruptured amniotic membranes. Investigators wish to study and compare the effect of this technique versus conventional primary skin closure on wound infection and incidence of secondary wound suturing in CS with ruptured membranes.
MATERIALS AND METHODS:
- STUDY DESIGN: Randomized controlled Trial
- STUDY SETTING: Tertiary teaching hospital-based trial involving obstetric patients undergoing Caesarean delivery.
- PLACE OF STUDY: Department of Obstetrics and Gynecology, Calcutta National Medical College and Hospital, Kolkata.
- PERIOD OF STUDY: From 1st March 2020 to 15th June 2021.
- SAMPLE SIZE: As no similar study was found in literature related to obstetric population, we have chosen an arbitrary sample size of 30 in case group and 30 in control group in this Pilot study.
- STUDY POPULATION:
INCLUSION CRITERIA :
- Parturients admitted with rupture of membranes undergoing emergency CS
EXCLUSION CRITERIA :
- Presence of intact membranes
- Incision other than Pfannenstiel
- Presence of pre-existing infection at the site of skin incision
- Presence of obvious chorioamnionitis
- Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
- Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.
- PROCEDURE:
Mothers undergoing emergency CS for various indications after rupture of membranes will be randomly allocated to two groups Study group to undergo Delayed Primary Closure of skin incision and Control group to undergo Primary closure of skin incision, after appropriate consenting.
During CS Pfannenstiel incision will be made in the skin. All patients will receive prophylactic antibiotic within thirty minutes of making abdominal incision. Depending upon the duration of membrane rupture wound will be defined either contaminated (duration of membrane rupture ≥ 12 hours) or clean contaminated (duration of membrane rupture ≤12 hours).
At the end of the procedure after closure of rectus sheath in the Study group, interrupted stitches will be taken through skin and subcutaneous tissue with 1-0 monofilament suture but knots will not be tightened and skin will be left open. Following operation, from next day onwards dressing of the wound will be done for 3 days. On 4th day, the monofilament stitches will be tightened under local anaesthesia to appose the skin. Thereafter, sutures will be removed on 7th day after operation.
In the Control group wound margins will be apposed by primary closure by interrupted stitches using 1-0 monofilament and stitches will be removed on 6th day after operation.
If there is abnormal discharge from wound, wound swabs will be taken for bacterial culture sensitivity test.
If there is wound dehiscence, timing of secondary closure will be decided based on wound health and presence of adequate granulation tissue after a period of regular wound dressing.
STASTICAL ANALYSIS PLAN Statistical methods- Linear data will be represented a mean ± standard deviation for normally distributed data and as mean (interquartile range (IQR)) for not-normally distributed data. Categorical data will represented as percentage (frequency). Comparison of means will be done with Mann Whitney U test and comparison of proportions with Chi - squared test or Fisher's exact test as appropriate. Multivariate modeling with logistic regression will be used to compare different variables between the primary closure and delayed primary closure groups.
- Being tested
- Delayed primary closure of skin incision in Caesarean section in experimental group, Primary closure of skin incision in Caesarean section in active comparator group
- Medical subject headings
- Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Delayed primary closure of skin incision in Caesarean section in experimental groupProcedure or surgery
Delayed closure of skin wound of emergency Caesarean section following wound dressing for 2-3 days in experimental group
Primary closure of skin incision in Caesarean section in active comparator groupProcedure or surgery
Primary closure of skin wound (incisional) at the time of emergency Caesarean section in active comparator group
| Study group | Role | What they receive |
|---|---|---|
| Primary closure of Cesarean wound | Active comparator | Immediate closure of skin incision where healing occurs by primary intention Receives: Procedure: Primary closure of skin incision in Caesarean section in active comparator group |
| Delayed primary closure of Cesarean wound | Experimental | Delayed closure of skin incision following regular wound dressing for 2 to 3 days. Receives: Procedure: Delayed primary closure of skin incision in Caesarean section in experimental group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Surgical site infections requiring secondary closure
Incidence of surgical site infections requiring secondary closure
Measured: 6 days from the day of surgery
Secondary outcomes (1)
Prolonged hospital stay
Requiring prolonged hospital stay due to wound infection
Measured: more than 7 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Oct 2020
- Study start1 Mar 2021
- Primary completion15 Jun 2021
- Study completion15 Jun 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cesarean Wound DisruptionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Patients were randomized to delayed primary closure (group A, n=40) or primary closure (group B, n=30)
- Masking
- None (open label)
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr.Jhuma Biswas
- Sponsor type
- Other government
- Responsible party
- Sponsor-investigator, Dr.Jhuma Biswas, Calcutta National Medical College and Hospital
- Investigators
- Jhuma Biswas, MBBS, MS, Principal investigator, Dept. of Obstetrics and Gynecology, Calcutta National Medical College and Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04587960
- Sponsor's protocol ID
- ECR/771/Inst/WB/2015/RR-18
- Status last verified
- Sep 2021
- First submitted
- 8 Oct 2020
- Last updated
- 1 Oct 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: IPD would be used for this study only
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparative Study of Outcome Between Primary Closure and Delayed Primary Closure of Skin Incision in Emergency Caesarean Section
- ClinicalTrials.gov ID
- NCT04587960
- Acronym / sponsor ID
- ECR/771/Inst/WB/2015/RR-18
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Dr.Jhuma BiswasOther government
- Study start
- 1 Mar 2021 (actual)
- Primary completion
- 15 Jun 2021 (actual)
- Study completion
- 15 Jun 2021 (actual)
- First posted
- 14 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.
Detailed description
OBJECTIVE
- To compare the effect of two different methods of skin wound closure namely Primary Closure and Delayed Primary Closure on the incidence of wound infection and requirement for secondary skin wound repair after emergency caesarean section in patients with ruptured membranes.
RESEARCH HYPOTHESIS Caesarean Sections (CS) in emergency situation where amniotic membrane is ruptured are clean contaminated procedures which are associated with 10-20% wound disruptions. Delayed Primary Closure for managing contaminated wounds is a concept well recognized by military surgeons, which reduces wound infections. Investigators wish to conduct this prospective study to determine the efficacy of using this technique of wound closure in Caesarean Sections in patients with history of ruptured amniotic membranes. Investigators wish to study and compare the effect of this technique versus conventional primary skin closure on wound infection and incidence of secondary wound suturing in CS with ruptured membranes.
MATERIALS AND METHODS:
- STUDY DESIGN: Randomized controlled Trial
- STUDY SETTING: Tertiary teaching hospital-based trial involving obstetric patients undergoing Caesarean delivery.
- PLACE OF STUDY: Department of Obstetrics and Gynecology, Calcutta National Medical College and Hospital, Kolkata.
- PERIOD OF STUDY: From 1st March 2020 to 15th June 2021.
- SAMPLE SIZE: As no similar study was found in literature related to obstetric population, we have chosen an arbitrary sample size of 30 in case group and 30 in control group in this Pilot study.
- STUDY POPULATION:
INCLUSION CRITERIA :
- Parturients admitted with rupture of membranes undergoing emergency CS
EXCLUSION CRITERIA :
- Presence of intact membranes
- Incision other than Pfannenstiel
- Presence of pre-existing infection at the site of skin incision
- Presence of obvious chorioamnionitis
- Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
- Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.
- PROCEDURE:
Mothers undergoing emergency CS for various indications after rupture of membranes will be randomly allocated to two groups Study group to undergo Delayed Primary Closure of skin incision and Control group to undergo Primary closure of skin incision, after appropriate consenting.
During CS Pfannenstiel incision will be made in the skin. All patients will receive prophylactic antibiotic within thirty minutes of making abdominal incision. Depending upon the duration of membrane rupture wound will be defined either contaminated (duration of membrane rupture ≥ 12 hours) or clean contaminated (duration of membrane rupture ≤12 hours).
At the end of the procedure after closure of rectus sheath in the Study group, interrupted stitches will be taken through skin and subcutaneous tissue with 1-0 monofilament suture but knots will not be tightened and skin will be left open. Following operation, from next day onwards dressing of the wound will be done for 3 days. On 4th day, the monofilament stitches will be tightened under local anaesthesia to appose the skin. Thereafter, sutures will be removed on 7th day after operation.
In the Control group wound margins will be apposed by primary closure by interrupted stitches using 1-0 monofilament and stitches will be removed on 6th day after operation.
If there is abnormal discharge from wound, wound swabs will be taken for bacterial culture sensitivity test.
If there is wound dehiscence, timing of secondary closure will be decided based on wound health and presence of adequate granulation tissue after a period of regular wound dressing.
STASTICAL ANALYSIS PLAN Statistical methods- Linear data will be represented a mean ± standard deviation for normally distributed data and as mean (interquartile range (IQR)) for not-normally distributed data. Categorical data will represented as percentage (frequency). Comparison of means will be done with Mann Whitney U test and comparison of proportions with Chi - squared test or Fisher's exact test as appropriate. Multivariate modeling with logistic regression will be used to compare different variables between the primary closure and delayed primary closure groups.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Patients were randomized to delayed primary closure (group A, n=40) or primary closure (group B, n=30)
| Arm | Type | Receives |
|---|---|---|
| Primary closure of Cesarean wound | Active comparator | Procedure: Primary closure of skin incision in Caesarean section in active comparator groupImmediate closure of skin incision where healing occurs by primary intention |
| Delayed primary closure of Cesarean wound | Experimental | Procedure: Delayed primary closure of skin incision in Caesarean section in experimental groupDelayed closure of skin incision following regular wound dressing for 2 to 3 days. |
Who may qualify
- Ages
- 21 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Parturients admitted with rupture of membranes undergoing emergency CS
Key exclusion criteria (6 listed)
- Presence of intact membranes
- Incision other than Pfannenstiel
- Presence of pre-existing infection at the site of skin incision
- Presence of obvious chorioamnionitis
- Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Delayed primary closure of skin incision in Caesarean section in experimental groupDelayed closure of skin wound of emergency Caesarean section following wound dressing for 2-3 days in experimental group | Procedure or surgery | Delayed primary closure of Cesarean wound |
| Primary closure of skin incision in Caesarean section in active comparator groupPrimary closure of skin wound (incisional) at the time of emergency Caesarean section in active comparator group | Procedure or surgery | Primary closure of Cesarean wound |
Primary outcome
Surgical site infections requiring secondary closure
Time frame: 6 days from the day of surgery
Incidence of surgical site infections requiring secondary closure
1 secondary outcome
Prolonged hospital stay
Time frame: more than 7 days after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2021.
- Individual participant dataSharing planned: No. IPD would be used for this study only
Related trials for Cesarean Wound Disruption
Not yet recruitingObservational study
Timing of Cesarean Wound Dressing Removal on Wound Healing in Women With BMI ≥ 30 kg/m²
Cesarean Section, Surgical Wound Infection
Not yet recruiting
Effect of Bioptron Light Therapy on Wound Healing After Caesarean Section
Cesarean Section; Complications, Wound, Dehiscence
Recruiting
Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions
Cesarean Section, Surgical Site Infection
Not yet recruitingObservational study
Ultrasound Model to Help Differentiate Between Placenta Accreta Spectrum and Uterine Dehiscence in 3rd Trimester Pregnancies
Placenta Accreta, Third Trimester, Uterine Scar Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jhuma Biswas, MBBS, MS principal investigator
Dept. of Obstetrics and Gynecology, Calcutta National Medical College and Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Delayed primary closure of skin incision in Caesarean section in experimental group and Primary closure of skin incision in Caesarean section in active comparator group in people with Cesarean Wound Disruption and Cesarean Section; Infection, run by Dr.Jhuma Biswas at 1 site in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Surgical site infections requiring secondary closure (time frame: 6 days from the day of surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2021.